Published in Telemedicine Week, July 6th, 2004
Net proceeds from this offering were approximately $59,700,000. The company has granted to the underwriters a 30-day option to purchase an additional 825,000 shares of common stock at the initial public offering price to cover over allotments, if any. The shares will be listed on the NASDAQ Stock Market's National Market under the symbol "DRAD."
The joint managers for the offering are Merrill Lynch, Pierce, Fenner and Smith, Inc., and J.P. Morgan Securities, Inc., Banc of America Securities LLC and William...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Telemedicine Week